Anticoagulation Forum

AC Forum Turns 30!

We are so excited to celebrate our 30 years of education and impact and to welcome our new president, Dr. Allison Burnett!!

Watch the video below to hear AC Forum leaders share their stories, experiences, and future goals for our organization!

30th ANNIVERSARY HIGHLIGHT VIDEO



Missed our 30th Anniversary Virtual Celebration? Check out the recording here to view the full presentation!

Managing Anticoagulation During the COVID-19 Pandemic

AC Forum will continue to offer guidance on how best to protect your patients and staff while providing anticoagulation management during the current pandemic. Check back often for new updates!

IDEA Committee

In recognizing the impact of systemic racism on health disparities, the Anticoagulation Forum has established the Inclusion, Diversity, Equity, and Allyship (IDEA) Committee. Through the IDEA Committee, the AC Forum will work to increase awareness and promote diversity in our leadership, membership, and programming. We hope our members will engage in this initiative to re-evaluate their current practice, reduce health inequities, and improve the quality of care for all patients.

Learn more here.

News & Announcements:

May Webinar: Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Valvular Atrial Fibrillation

Don’t miss our upcoming webinar on Wednesday, May 25, 2021 @ 12:00 PM ET.

Direct oral anticoagulants (DOACs) are increasingly used in place of warfarin, but evidence about their effectiveness and safety in patients with valvular atrial fibrillation (AF) remains limited.

In this comparative effectiveness study using practice-based claims data, patients with valvular AF who were new users of DOACs had lower risks for ischemic stroke or systemic embolism and major bleeding than new users of warfarin. This data may be used to guide risk–benefit discussions regarding anticoagulant choices for patients with valvular AF.

Please join us for this webinar as the authors discuss the effectiveness and safety of DOACs compared with warfarin in patients with valvular AF.

Authors:
• Geoffrey Barnes, MD, MSc
• Adam Cuker, MD, MS
• Ghadeer Dawwas, MSc, MBA, PhD

Moderators:
• Arthur Allen, PharmD, CACP
• Diane Wirth, ANP, CACP



Link to article here


We are pleased to provide enduring accreditation for this webinar!


Practitioner's Guide for Improving Oral Anticoagulant Use, Online CE from the FDA (CE), June 2020

Free 1-hour course from the FDA on all the fundamental aspects of oral anticoagulation management including overviews of disease state & risk assessment, warfarin, DOACs, DDIs and patient issues such as compliance & joint decision-making; slides and transcript available for download; 1 hour of continuing education credit is available for physicians, nurses & pharmacists until 6/1/23.

View Course Here  


FDA-funded Anticoagulation Stewardship Guide

Download our new FDA-funded release, Core Elements of the Anticoagulation Stewardship Program, which outlines systemic protocols designed  to improve the safety  and quality of care for patients and reduce the adverse drug effects related to anticoagulant medications. 

 

Upcoming Events

Follow Us On Twitter


Sponsored by: